neupro
Pharmaranks rates Neupro 3.5/5 for recall safety — an independent score from its FDA recall history and its manufacturer's record. Neupro (Rotigotine) is a nonergot dopamine agonist used to treat Parkinson Disease, Restless Legs Syndrome.
Rotigotine · by Ucb Inc
Based on 1 source · Recall-safety score from FDA recall history — this product's own recalls and its manufacturer's record. Not an efficacy or quality rating. methodology →
Key facts
- Active ingredient
- Rotigotine
- Drug class
- Nonergot Dopamine Agonist
- Form
- Patch, extended release, Kit
- Strength
- Rotigotine 1MG/24HR · Rotigotine 2MG/24HR · Rotigotine 3MG/24HR · Rotigotine 4MG/24HR · Rotigotine 6MG/24HR · Rotigotine 8MG/24HR
- Type
- Prescription (Rx)
- Brand or generic
- Brand-name
- May treat
- parkinson disease, restless legs syndrome
- Manufacturer
- Ucb Inc
- FDA application
- NDA021829
Drug class
May treat (source: NIH RxClass)
See how Neupro ranks — best-rated nonergot dopamine agonist for:
Dosage forms
Patch, extended release and Kit
The forms currently marketed in the U.S., per the FDA National Drug Code Directory.
Ways to save
Ask for the generic
Same active ingredient, far cheaper. Is there a generic? →
Request a 90-day supply
Bulk fills usually lower the per-dose price vs monthly refills.
Use copay cards
Manufacturer copay cards & patient-assistance programs — especially for brand drugs.
Compare alternatives
A same-class option may cost less. See alternatives →
Frequently asked questions
- What does Neupro treat?
- Neupro (Rotigotine) may be used to treat parkinson disease, restless legs syndrome, based on NIH RxClass drug-classification data (conditions a drug may treat — not a verbatim copy of the FDA-approved label). This is general reference, not medical advice.
- How is Neupro rated?
- pharmaranks gives Neupro a composite score of 3.5 out of 5, currently based on 1 weighted source (FDA regulatory recall-safety data weighted highest). See our methodology at /how-we-rate.
- Is there a coupon or discount for Neupro?
- pharmaranks is an independent ratings site, not a pharmacy — we don't issue coupons or sell Neupro. To pay less, ask your prescriber or pharmacist whether a generic equivalent exists, check the manufacturer's copay/savings card and patient-assistance program, and compare a pharmacy discount card against your insurance copay. Prices vary by pharmacy, insurance, and location, so always confirm at the counter. This is general reference, not medical or financial advice.
- Who makes Neupro?
- Neupro is marketed by Ucb Inc. You can see Ucb Inc's full profile, rating, and other products on pharmaranks.
- Is Neupro a brand-name or generic drug?
- Neupro is a brand-name product with the active ingredient Rotigotine.
- Is Neupro available over the counter?
- No. Neupro is a prescription (Rx) medication in the US — you need a prescription from a licensed clinician (in person or via telehealth); it isn't sold over the counter. For some conditions there are OTC alternatives — ask your pharmacist.
- What forms does Neupro come in?
- Neupro is currently marketed as patch, extended release and kit, per the FDA's National Drug Code Directory.
- What class of drug is Neupro?
- Neupro is classified as nonergot dopamine agonist, per the FDA's Established Pharmacologic Class.
- Is Neupro FDA-registered?
- Neupro is on record with the U.S. FDA under application number NDA021829. You can verify this on its official FDA label.
- Has Neupro been recalled by the FDA?
- Neupro has no FDA recalls recorded under its own application in the openFDA enforcement database. Its recall-safety score reflects its manufacturer's overall recall record. This is general reference, not medical advice — check the FDA recall database for the latest alerts.
- Is Neupro safe?
- There's no single safe-or-not verdict. pharmaranks gives Neupro a recall-safety score of 70/100, based on its FDA recall history (no recalls under its own FDA application) — not an efficacy or side-effect rating. Review its FDA-label side effects and warnings before use, and always consult a licensed professional.
Information is sourced from public FDA regulatory data. Provided for general reference only — not medical advice. Always consult a licensed professional and the current prescribing information.
What people report to the FDA about ROTIGOTINE
The FDA Adverse Event Reporting System (FAERS) collects reports from patients and clinicians. It holds 4,588 reports naming ROTIGOTINE — the active ingredient in Neupro, and the FDA flagged 92% of those reports as serious. The effects reported most often — leaving out reports about overdose, misuse or the condition being treated, which dominate the raw list for common medicines:
- fall435 reports
- parkinson^s disease358 reports
- dyskinesia250 reports
- tremor250 reports
- hallucination228 reports
- product adhesion issue226 reports
- pneumonia203 reports
- anxiety178 reports
Read these as a signal, not a rate. A report does not mean ROTIGOTINE caused the effect — anyone can file one, and many describe people taking several medicines for several conditions. Crucially there is no denominator: FAERS does not record how many people took the drug, so these counts cannot be turned into “X% of patients” — a bigger number often just means a more widely used or more talked-about drug. Duplicates exist, and publicity drives reporting. For what is actually established, read the FDA label.
Source: openFDA drug/event (FAERS), retrieved September 26, 2026.
Reviews
No reviews yet. Be the first to write one.
People also viewed
Compare Neupro head-to-head
Browse medications A–Z
Research products from A to Z, compare independent ratings, and find alternatives.
neupro
70/100